Overactive Bladder
Healthcare and economic burden of anticholinergic use in adults with overactive bladder: a systematic literature review.
November 20, 2022
Urovant Sciences® Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Season
November 14, 2022
Safety and tolerability of solifenacin in children and adolescents with overactive bladder- a systematic review.
November 13, 2022
Sacral neuromodulation: Rechargeable versus non-rechargeable device. What would the patient preferences be in France?
November 13, 2022
Bullseye Technique to Optimize S3 Foramen Access: Applying a Trusted Endourology Technique to Pelvic Medicine.
November 13, 2022
Efficacy and safety of combination of mirabegron and solifenacin in patients with double-J stent related overactive bladder: a prospective study.
November 13, 2022
Evaluation of Overactive Bladder Symptoms in Patients Recovering from Post-Acute COVID-19 Syndrome.
November 6, 2022
Are β3 -adrenoceptor gene polymorphisms relevant for urology?
November 6, 2022
The detection of urinary viruses is associated with aggravated symptoms and altered bacteriome in female with overactive bladder.
October 30, 2022
Detailed Investigation of Bladder Diary Parameters During Sacral Neuromodulation in Patients With Overactive Symptoms.
October 30, 2022
Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysis.
October 30, 2022
Incidence of New or Worsening Overactive Bladder Among Patients with a Prior SARS-CoV-2 Infection: A Cohort Study.
October 23, 2022
Treatment for overactive bladder: A meta-analysis of tibial versus parasacral neuromodulation.
October 23, 2022
Compliance with Percutaneous Tibial Nerve Stimulation at a Tertiary Academic Center versus a County Hospital.
October 23, 2022
Overactive bladder: not just a normal part of getting older.
October 16, 2022